
Zhejiang Huahai Pharmaceutical Co., Ltd.
SSE:600521.SS
20.5 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 9,547.425 | 8,308.72 | 8,265.745 | 6,643.573 | 6,485.213 | 5,388.095 | 5,094.596 | 5,002.003 | 4,092.853 | 3,500.362 | 2,584.988 | 2,296.408 | 2,014.391 | 1,827.614 | 1,022.845 | 927.967 | 801.432 | 706.981 | 557.26 | 423.246 | 391.129 | 303.036 | 187.378 | 177.806 | 136.006 |
Cost of Revenue
| 3,636.604 | 3,288.338 | 3,110.936 | 2,657.134 | 2,352.223 | 2,126.383 | 2,050.476 | 2,202.668 | 2,052.665 | 1,777.49 | 1,430.074 | 1,289.258 | 1,203.228 | 1,103.301 | 593.529 | 541.002 | 430.04 | 377.064 | 287.961 | 189.71 | 193.986 | 141.6 | 86.346 | 101.595 | 64.637 |
Gross Profit
| 5,910.821 | 5,020.382 | 5,154.809 | 3,986.439 | 4,132.991 | 3,261.712 | 3,044.12 | 2,799.335 | 2,040.188 | 1,722.872 | 1,154.914 | 1,007.149 | 811.163 | 724.313 | 429.316 | 386.965 | 371.392 | 329.917 | 269.299 | 233.536 | 197.143 | 161.436 | 101.032 | 76.211 | 71.368 |
Gross Profit Ratio
| 0.619 | 0.604 | 0.624 | 0.6 | 0.637 | 0.605 | 0.598 | 0.56 | 0.498 | 0.492 | 0.447 | 0.439 | 0.403 | 0.396 | 0.42 | 0.417 | 0.463 | 0.467 | 0.483 | 0.552 | 0.504 | 0.533 | 0.539 | 0.429 | 0.525 |
Reseach & Development Expenses
| 986.685 | 982.994 | 925.529 | 942.264 | 565.697 | 467.358 | 396.759 | 348.269 | 339.396 | 267.089 | 212.752 | 155.751 | 93.317 | 84.635 | 70.042 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 682.072 | 610.41 | 669.843 | 683.088 | 546.082 | 387.792 | 401.084 | 323.093 | 246.914 | 204.553 | 121.609 | 97.978 | 104.19 | 118.538 | 110.223 | 166.527 | 148.319 | 104.446 | 101.538 | 54.834 | 36.626 | 31.892 | 21.54 | 19.299 | 14.883 |
Selling & Marketing Expenses
| 1,572.226 | 1,294.782 | 1,244.237 | 1,179.106 | 996.334 | 960.545 | 1,294.367 | 904.65 | 614.718 | 448.118 | 274.469 | 150.994 | 83.217 | 49.275 | 42.54 | 27.161 | 23.447 | 17.457 | 17.606 | 12.991 | 12.682 | 6.53 | 3.946 | 2.954 | 1.417 |
SG&A
| 2,254.298 | 1,806.645 | 1,914.08 | 1,862.194 | 1,542.416 | 1,348.337 | 1,695.451 | 1,227.742 | 861.632 | 652.671 | 396.078 | 248.972 | 187.407 | 167.813 | 152.763 | 193.688 | 171.766 | 121.902 | 119.144 | 67.825 | 49.309 | 38.422 | 25.486 | 22.254 | 16.3 |
Other Expenses
| 1,199.049 | 1,020.757 | 587.67 | 525.255 | 433.09 | 326.402 | -317.997 | -11.933 | 62.264 | 36.098 | -8.686 | 15.2 | 47.367 | 1.177 | 31.659 | 26.594 | 2.779 | 4.682 | 7.455 | 8.05 | 7.972 | -4.317 | -0.622 | -1.453 | -0.847 |
Operating Expenses
| 4,440.032 | 3,808.083 | 3,427.278 | 3,329.713 | 2,541.202 | 2,142.098 | 2,246.711 | 1,899.712 | 1,511.277 | 1,182.106 | 806.751 | 580.278 | 419.037 | 396.797 | 318.097 | 202.365 | 177.612 | 127.753 | 123.233 | 71.149 | 51.148 | 39.865 | 26.355 | 23.074 | 17.757 |
Operating Income
| 1,470.789 | 1,124.54 | 1,547.171 | 868.399 | 1,286.555 | 824.375 | 475.239 | 791.179 | 507.898 | 493.1 | 307.361 | 399.848 | 355.969 | 274.12 | 97.182 | 170.42 | 168.481 | 184.787 | 143.263 | 168.992 | 155.914 | 124.597 | 72.75 | 55.345 | 53.15 |
Operating Income Ratio
| 0.154 | 0.135 | 0.187 | 0.131 | 0.198 | 0.153 | 0.093 | 0.158 | 0.124 | 0.141 | 0.119 | 0.174 | 0.177 | 0.15 | 0.095 | 0.184 | 0.21 | 0.261 | 0.257 | 0.399 | 0.399 | 0.411 | 0.388 | 0.311 | 0.391 |
Total Other Income Expenses Net
| -7.18 | -24.218 | -38.272 | -81.471 | -131.418 | -63.511 | -198.524 | -71.125 | 59.068 | 30.69 | -14.058 | 12.452 | 45.897 | -0.965 | 30.619 | 25.04 | -26.112 | -13.17 | 5.48 | 7.185 | 16.451 | -4.622 | -1.88 | -1.624 | -1.019 |
Income Before Tax
| 1,463.608 | 1,100.321 | 1,508.9 | 786.928 | 1,215.355 | 760.864 | 157.242 | 779.247 | 567.066 | 523.79 | 312.947 | 412.299 | 401.866 | 273.155 | 127.802 | 195.46 | 167.667 | 188.995 | 148.743 | 176.177 | 163.166 | 119.975 | 72.112 | 53.721 | 52.131 |
Income Before Tax Ratio
| 0.153 | 0.132 | 0.183 | 0.118 | 0.187 | 0.141 | 0.031 | 0.156 | 0.139 | 0.15 | 0.121 | 0.18 | 0.199 | 0.149 | 0.125 | 0.211 | 0.209 | 0.267 | 0.267 | 0.416 | 0.417 | 0.396 | 0.385 | 0.302 | 0.383 |
Income Tax Expense
| 356.145 | 283.072 | 332.89 | 306.284 | 220.757 | 154.039 | 22.341 | 155.659 | 110.167 | 87.069 | 56.216 | 48.877 | 63.372 | 59.066 | 34.27 | 31.073 | 17.809 | 56.948 | 38.675 | 47.187 | 44.039 | 40.682 | 21.507 | 10.837 | 17.425 |
Net Income
| 1,118.981 | 830.466 | 1,167.759 | 487.535 | 929.815 | 569.595 | 107.515 | 639.247 | 500.831 | 442.472 | 265.501 | 359.168 | 341.123 | 216.906 | 93.587 | 164.978 | 150.066 | 132.026 | 110.014 | 128.913 | 119.112 | 79.284 | 50.593 | 42.61 | 34.349 |
Net Income Ratio
| 0.117 | 0.1 | 0.141 | 0.073 | 0.143 | 0.106 | 0.021 | 0.128 | 0.122 | 0.126 | 0.103 | 0.156 | 0.169 | 0.119 | 0.091 | 0.178 | 0.187 | 0.187 | 0.197 | 0.305 | 0.305 | 0.262 | 0.27 | 0.24 | 0.253 |
EPS
| 0.77 | 0.57 | 0.81 | 0.34 | 0.64 | 0.39 | 0.082 | 0.46 | 0.37 | 0.33 | 0.2 | 0.28 | 0.28 | 0.18 | 0.075 | 0.14 | 0.12 | 0.11 | 0.089 | 0.1 | 0.077 | 0.051 | 0.05 | 0.038 | 0.031 |
EPS Diluted
| 0.77 | 0.57 | 0.8 | 0.34 | 0.64 | 0.39 | 0.082 | 0.46 | 0.37 | 0.33 | 0.2 | 0.28 | 0.28 | 0.18 | 0.075 | 0.14 | 0.12 | 0.11 | 0.089 | 0.1 | 0.077 | 0.051 | 0.05 | 0.038 | 0.031 |
EBITDA
| 2,600.182 | 2,155.404 | 2,454.118 | 1,564.882 | 1,855.597 | 1,465.31 | 669.896 | 1,125.576 | 863.374 | 745.766 | 493.904 | 579.862 | 530.442 | 375.555 | 208.702 | 253.229 | 253.582 | 255.418 | 195.327 | 204.419 | 182.029 | 135.473 | 86.618 | 64.444 | 55.382 |
EBITDA Ratio
| 0.272 | 0.259 | 0.297 | 0.236 | 0.286 | 0.272 | 0.131 | 0.225 | 0.211 | 0.213 | 0.191 | 0.253 | 0.263 | 0.205 | 0.204 | 0.273 | 0.316 | 0.361 | 0.351 | 0.483 | 0.465 | 0.447 | 0.462 | 0.362 | 0.407 |